A role for CD38 in RA pathology is also suggested by increased CD38 expression in RA patients synovial tissues, high percentages of circulating CD38+CD3+ and CD38+CD56+ cells, and high levels of rheumatic factor (120, 127, 128). The gene discussed is NCAM1; the disease is rheumatoid arthritis.